- Home
- PHIO vs MTNB Comparison
PHIO vs MTNB Comparison
Compare PHIO & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- MTNB
- Stock Information
- Founded
- PHIO 2011
- MTNB 2013
- Country
- PHIO United States
- MTNB United States
- Employees
- PHIO N/A
- MTNB N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- PHIO Health Care
- MTNB Health Care
- Exchange
- PHIO Nasdaq
- MTNB Nasdaq
- Market Cap
- PHIO 2.3M
- MTNB 2.7M
- IPO Year
- PHIO N/A
- MTNB N/A
- Fundamental
- Price
- PHIO $2.61
- MTNB $0.56
- Analyst Decision
- PHIO Strong Buy
- MTNB Hold
- Analyst Count
- PHIO 1
- MTNB 1
- Target Price
- PHIO $36.00
- MTNB N/A
- AVG Volume (30 Days)
- PHIO 30.8K
- MTNB 81.2K
- Earning Date
- PHIO 11-14-2024
- MTNB 11-13-2024
- Dividend Yield
- PHIO N/A
- MTNB N/A
- EPS Growth
- PHIO N/A
- MTNB N/A
- EPS
- PHIO N/A
- MTNB N/A
- Revenue
- PHIO N/A
- MTNB N/A
- Revenue This Year
- PHIO N/A
- MTNB N/A
- Revenue Next Year
- PHIO N/A
- MTNB N/A
- P/E Ratio
- PHIO N/A
- MTNB N/A
- Revenue Growth
- PHIO N/A
- MTNB N/A
- 52 Week Low
- PHIO $2.17
- MTNB $0.50
- 52 Week High
- PHIO $10.35
- MTNB $21.50
- Technical
- Relative Strength Index (RSI)
- PHIO 48.74
- MTNB 32.26
- Support Level
- PHIO $2.58
- MTNB $0.51
- Resistance Level
- PHIO $2.91
- MTNB $0.60
- Average True Range (ATR)
- PHIO 0.21
- MTNB 0.05
- MACD
- PHIO 0.01
- MTNB 0.07
- Stochastic Oscillator
- PHIO 26.76
- MTNB 38.65
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.